2nd IAS Conference on HIV and Pathogenesis



Medical Advocates for Social Justice
An Index of Kaletra Posters, Abstracts, and News Releases from the

		2nd IAS Conference on HIV and Pathogenesis Paris, France July 14-17, 2003

Main New/Newsworthy Kaletra Library Conferences Home

Last Update: April 16, 2007
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader 5 .

CONFERENCE PDF POSTER
Steady-State Pharmacokinetics and Short-Term Virologic Response of Two Lopinavir/ritonavir (LPV/r) High-Dose Regimens in Multiple Antiretroviral-Experienced Subjects (Study 049)
C Flexner,Y-L Chiu, C Foit, et al.
Poster
CONFERENCE PDF POSTER
CD4 Cell Increases Through More Than 4 Years in Antiretroviral-Naïve HIV+ Patients Treated with Lopinavir/ritonavir-Based Therapy
H Kessler, M Heath-Chiozzi, M King, et al.
Poster

CONFERENCE PDF POSTER
SOKRATES: Prospective Evaluation of Resistance in Protease During Lopinavir/ritonavir Treatment
B da Silva, M King, P Cernohous, et al.
Poster

CONFERENCE PDF POSTER
Virological and Pharmacological Parameters Predicting the Response to Lopinavir/ritonavir
AG Marcellin, I Cohen-Codar, M King, et al
Poster

CONFERENCE PDF POSTER
Relationship Between Adherence and the Development of Viral Resistance in
Antiretroviral-Naive Patients Treated with Lopinavir/ritonavir (LPV/r) or Nelfinavir (NFV)
M King, S Brun, J Tschampa, et al
Poster

Depression in Patients after Substitution of their PI/NNRTI with Lopinavir/Ritonavir (LPV/r)
J Rockstroh, Y Shen, R Bortolozzi, et al.
Abstract

Salvage Therapy with Lopinavir/Ritonavir (LPV/R), Amprenavir (APV) ± an Additional Boost with Ritonavir (RTV): 1-Year Results of Puzzle 1-ANRS104 Study
G Raguin, G Chene L Morand-Joubert, et al
Abstract

The LOPSAQ Study: 24 Week Analysis of the Double Protease Inhibitor (PI) Salvage Therapy Regimen Containing Lopinavir (LPV/r) plus Saquinavir (SQV) without any additional Antiretroviral (ART) Therapy
S Staszewski, B Dauer, N Von Hentig, et al
Abstract

Interleukin-7 Levels Predict Treatment Response in Advanced HIV-Infected Subjects Receiving Lopinavir/Ritonavir Therapy
JP Routy, GHR Smith, N Gilmore, et al
Abstract

HIV Patients Experiencing Moderate Side Effects Reported Improved Outcomes when
Changed to a Regimen Containing Kaletra
July 14, 2003
News Release

Main New/Newsworthy Kaletra Library Conferences Home

Kaletra Posters, Abstracts, and News Releases
2nd IAS Conference on HIV and Pathogenesis
A Medical Advocates for Social Justice Update